Protein Stability Analysis Market is Predicted to Observe a Tremendous Growth, With a CAGR of 10.8% From 2020 To 2026: Grand View Research Inc.
The global protein
stability analysis market
size is expected to reach USD 2.0
billion by 2026, expanding at a CAGR
of 10.8%, according to a new report by Grand View Research, Inc. Protein
stability analysis is an essential step in therapeutics stability studies that
enables the assessment of factors causing aggregation and degradation of
proteins. This analysis keeps a check on the biologic activity, quality, and
product safety of biopharmaceuticals. The recent approvals of recombinant
protein therapeutics increase the demand for this analysis during the drug
development programs.
Biopharmaceutical innovators are at the
forefront of the human response to the coronavirus pandemic. A significant
number of major biotech firms are in the midst of a race to investigate the
Sars-Cov-2 genome and prepare a viable vaccine for the same. As compared to the
speed of response to SARS/MERs etc, the biotech entities are investigating
SARs-Cov-2 at an unprecedented rate and a considerable amount of funds are
being put into the R&D. With multiple candidates in trial, the public and
private sectors are anticipated to work in unison for the foreseeable period,
until a vaccine is developed for Covid-19. The report will account for Covid19
as a key market contributor.
Rising R&D in the
biopharmaceuticals arena has pronounced the demand for protein stability
protocols. The drug manufacturers are adopting the stability-indicating methods
for degradation pathway analysis and stress testing for the development of
effective and safe therapeutics. Moreover, government agencies are encouraging
the drug safety programs by raising funds in the field of proteomics industry,
which in turn, surge the adoption of stability analysis.
For instance, in January 2018, funding
of USD 18 million from the Genome Canada and Genome BC supported the protein
research of the University of Victoria, Canada. Besides, key companies are also
entering into collaborations with the venture capitalists for funds to expand
their stability analysis portfolio.
To Request Sample Copy of this report, click the link:
https://www.grandviewresearch.com/industry-analysis/protein-stability-analysis-market/request/rs1
Ionic liquids are extensively applied
in biological systems as environmentally friendly solvents. It is crucial to
analyze the effect of ionic liquids over protein stability as it is helpful in
the analysis of biological reaction processes. A study published in April 2020,
evaluated the thermodynamics of protein stability in ionic liquids by the
utilization of Fluorine-19 nuclear magnetic resonance spectroscopy. Such
studies are expected to increase the adoption of protein stability techniques
over the forecast period.
Protein Stability
Analysis Market Report Highlights
- Reagents and assay kits accounted for the
largest share in 2020 owing to frequent usage of these products and low
cost associated with them as compared to other product types
- Broadening application of analytical
instruments that are designed to assess several stability-indicating
parameters using ultra-low sample volumes at high speed drives the
instrument segment with the fastest CAGR
- Differential Scanning Calorimetry (DSC)
held the largest revenue share in 2020 due to numerous advantages of DSC
over other determination methods
- These benefits include simple sample
preparation, easy implementation of DSC in both solid and liquid samples,
and determination of thermodynamic parameters
- Differential Scanning Fluorimetry (DSF)
technique is expected to register the fastest growth rate due to the
rising implementation of nanoDSF technique in analytical studies
- This is attributive to the fact that
nanoDSF rapidly and reliably determines the melting point of crude
extracts, thus eliminating the requirement for cost and time-intensive
protein analysis steps
- Pharmaceutical and biotechnology
companies dominated the protein stability analysis market in 2020 due to
the presence of well-established drug manufacturers that are capable of
performing in-house production of biologics
- Contract Research Organizations (CROs)
are anticipated to witness a lucrative growth rate during the forecast
period
- CROs provide a range of capabilities in
protein engineering with integrated platforms and technologies across
various geographical regions to support the development of recombinant
protein therapeutics
- A large number of proteomics projects
conducted in U.S. and high focus on proteomics research activities by
national agencies marks the dominant share of North America
- Asia Pacific is expected to witness the
fastest growth rate owing to the rising number of conferences and events
conducted to raise awareness about the products available for stability analysis
- Key players such as Enzo Biochem, Thermo
Fisher, PerkinElmer, NanoTemper, and GE Healthcare, have adopted several
strategic initiatives to reinforce their market presence.
The development of new high-throughput
techniques, such as Stable-seq by professionals at The American Society for
Biochemistry and Molecular Biology, Inc., which involves genetic selection in
combination with high-throughput DNA sequencing is anticipated to induce
growth. This approach effectively evaluates the in vivo stability of protein
variants, which is important for the identification of components in
proteolytic pathways that affect the protein turnover and associated
activities.
Outsourcing has been widely employed
in the drug development industry as a business strategy to enhance productivity
in drug development R&D activities and reduce drug development costs.
Several contract research organizations, including 2bind GmbH and LakePharma,
Inc., are offering stability analysis solutions with quality, accuracy, and robustness
within expected timelines. Moreover, compliance with regulatory expectations
supplements the adoption of outsourced services by pharmaceutical companies.
Constant efforts laid down by the
research groups to design software tools for analysis of protein stability are
expected to drive market growth. CUPSAT, designed by the University of Cologne,
is an easily accessible web tool for protein stability analysis based on point
mutations. This prediction model serves as a valuable tool for the analysis, with
an accuracy greater than 80%.
Have
a Query? Ask Our Expert:
https://www.grandviewresearch.com/inquiry/7113/ibb
The use of thermal proteome profiling
(TPP), provides a novel approach for protein stability analysis. TPP is based
on the principle that proteins develop a high resistance for heat-induced
unfolding by ligand binding. Hence, the improvements in instrumentation and
sample preparation for TPP enables the identification of even small stability
shifts in proteins.
Key
participants operating in the market for protein stability analysis include
Thermo Fisher Scientific, Inc; Enzo Biochem, Inc.; PerkinElmer Inc.;
NanoTemper; GE Healthcare; HORIBA, Ltd.; Malvern Panalytical Ltd.; Agilent
Technologies, Inc.; SETARAM Instrumentation; Unchained Labs; Waters
Corporation; and Applied Photophysics Ltd.
Key companies are adopting significant initiatives to reinforce
their market presence and maintain a competitive edge in the space. In
addition, market participants are involved in product development,
collaborative and partnership models, geographic expansion, and agreement
strategies in untapped regions.
For instance, in February 2020, NanoTemper Technologies
introduced NT. Robotic autosampler, which is designed to automate the
researcher’s workflow for screening a wide variety of candidates for protein
stability. This new system benefited the company’s protein stability analysis
portfolio due to high flexibility and small size, thereby accelerating the
company’s sales.
Grand View Research has segmented the global protein
stability analysis market based on product, technique, end use:
Protein Stability Analysis Product Outlook
(Revenue, USD Million, 2015 - 2026)
·
Reagents and Assay Kits
·
Instruments
·
Consumables and Accessories
·
Software
·
Service
Protein Stability Analysis Technique
Outlook (Revenue, USD Million, 2015 - 2026)
·
Chromatography
·
Spectroscopy
·
Differential Scanning Calorimetry (DSC)
·
Differential Scanning Fluorimetry (DSF)
·
Dynamic Light Scattering (DLS)
·
Others
Protein Stability Analysis End-use Outlook
(Revenue, USD Million, 2015 - 2026)
·
Pharmaceutical & Biotechnology
Companies
·
Contract Research Organizations
·
Academic Research Institutes
About Grand View Research
Grand View Research, Inc. is a U.S. based market research and
consulting company, registered in the State of California and headquartered in
San Francisco. The company provides syndicated research reports,
customized research reports, and consulting services. To help clients make
informed business decisions, we offer market intelligence studies ensuring
relevant and fact-based research across a range of industries, from technology
to chemicals, materials and healthcare.
For
More Information:www.grandviewresearch.com
Comments
Post a Comment